Background: Hepatocellular carcinoma (HCC) is increasing in incidence and treatment is often unsuccessful. Thus, prevention in high-risk patients with established cirrhosis has been proposed as an alt
Table S1. List of congenic DEGs in the Sall2 KO line (MEFs). Congenic DEGs with missense mutations are depicted in red. Table S2. DEGs between Sall2 WT and KO MEFs under doxorubicin perturbation (FDRâ
